SPP1 overexpression is associated with poor outcomes in ALK fusion lung cancer patients without receiving targeted therapy

The screening of non-small cell lung cancer (NSCLC) tumors for anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangements is important because of the dramatically favorable therapy response to ALK inhibitor. However, the exact mechanism of poor survival in ALK fusion lung cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiaolin, Liu, Yan, Mei, Fang, Li, Xinyang, Zhang, Mengxue, Yao, Buwen, Wu, Rui, You, Jiangfeng, Pei, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263595/
https://www.ncbi.nlm.nih.gov/pubmed/34234236
http://dx.doi.org/10.1038/s41598-021-93484-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263595/
https://www.ncbi.nlm.nih.gov/pubmed/34234236
http://dx.doi.org/10.1038/s41598-021-93484-2

Ejemplares similares